文献速递脑血管病

血管内取栓术后血压动态与结局的性别差异

Sex Differences in Blood Pressure Dynamics and Outcomes After Endovascular Thrombectomy.
PubMed 文献 · Neurology · 2026-11-09

该研究为ENCHANTED2/MT试验的探索性二次分析,纳入中国44家三级医院的816例取栓成功且再灌注后3小时内收缩压持续升高的急性缺血性卒中患者,评估血压动态与强化降压策略对90天改良Rankin量表结局的性别修饰效应。

要点

  • 男性强化降压与90天改良Rankin量表结局更差相关(acOR 1.91;95%CI 1.29-2.83)。
  • 女性强化降压的相应估计接近无效(acOR 0.94;95%CI 0.56-1.57)。
  • 男性平均收缩压每高5 mm Hg与90天结局更差相关(acOR 1.11;95%CI 1.03-1.20)。

核心结论

  • 在ENCHANTED2/MT的探索性二次分析中,随机血压管理策略和取栓术后早期血压动态与结局的关联存在性别分层差异。
  • 这些关联可能反映生物学性别及基线临床和血管特征的性别相关差异。
  • 这些发现是假设生成性的,在用于指导取栓术后性别特异性血压管理前应在前瞻性设计中证实。

研究设计与样本

  • ENCHANTED2/MT的探索性二次分析;该试验为在中国44家三级医院开展的多中心、开放标签、盲法终点随机试验。
  • 纳入标准:大血管闭塞所致急性缺血性卒中、取栓术后成功再灌注、再灌注后3小时内收缩压持续升高的成人患者。
  • 随机化后前72小时连续血压测量用于估计患者特异性平均血压轨迹和短期血压变异性,采用位置-尺度混合效应模型。
  • 共纳入816例患者(平均年龄67.6±12.0岁;38%为女性)。
  • 暴露包括平均血压、血压变异性和随机分配的强化 vs 标准降压策略;性别作为效应修饰因子评估。主要结局为90天改良Rankin量表(mRS)。

主要发现

  • 男性强化血压管理与更差的90天序贯mRS结局相关(校正共同比值比[acOR] 1.91;95%CI 1.29-2.83)。
  • 女性强化血压管理的相应估计接近无效(acOR 0.94;95%CI 0.56-1.57;acOR比值0.49;95%CI 0.26-0.94)。
  • 在随机化后血压暴露模型中,男性平均收缩压每高5 mm Hg与更差的90天mRS结局相关(acOR 1.11;95%CI 1.03-1.20)。
  • 女性平均收缩压每高5 mm Hg未见明确不良关联(acOR 0.95;95%CI 0.85-1.05;acOR比值0.85;95%CI 0.75-0.97)。
  • 收缩压变异性的性别差异关联较弱且不一致;次要结局方向相似但为探索性。

临床怎么用

  • 原文结论指出这些发现是假设生成性的,在用于指导取栓术后性别特异性血压管理前应在前瞻性设计中证实。

局限性

  • 本文为探索性二次分析。
  • 次要结局的发现为探索性。
  • 作者指出这些发现是假设生成性的,应在前瞻性设计中证实后才能用于指导取栓术后性别特异性血压管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Optimal blood pressure (BP) management after endovascular thrombectomy (EVT) for acute ischemic stroke (AIS) remains controversial, and whether early BP dynamics differentially affect outcomes among female and male participants is unclear. METHODS: This was an exploratory secondary analysis of ENCHANTED2/MT, a multicenter, open-label, blinded-end point randomized trial conducted in 44 tertiary hospitals in China. Eligible adults had AIS due to large-vessel occlusion, successful reperfusion after EVT, and persistent elevated systolic BP (SBP) within 3 hours after reperfusion. Serial BP measurements obtained during the first 72 hours after randomization were used to estimate patient-specific mean BP trajectories and short-term BP variability with a location-scale mixed-effects modeling approach. Associations of mean BP, BP variability, and randomized intensive vs standard BP lowering strategy with clinical outcomes were examined, with sex being evaluated as an effect modifier. The primary outcome was the 90-day modified Rankin Scale (mRS). RESULTS: Among 816 patients (mean age 67.6 ± 12.0 years; 38% female), intensive BP management was associated with worse 90-day ordinal mRS outcome among male participants (adjusted common odds ratio [acOR] 1.91; 95% CI 1.29-2.83), whereas the corresponding estimate among female participants was closer to null (acOR 0.94; 95% CI 0.56-1.57; ratio of acORs 0.49; 95% CI 0.26-0.94). In separate postrandomization BP exposure models, each 5 mm Hg higher mean SBP was associated with worse 90-day mRS outcome among male participants (acOR 1.11; 95% CI 1.03-1.20), whereas no clear adverse association was observed among female participants (acOR 0.95; 95% CI 0.85-1.05; ratio of acORs 0.85; 95% CI 0.75-0.97). SBP variability showed weaker and less consistent sex differential associations. Findings across secondary outcomes were directionally similar but exploratory. DISCUSSION: In this exploratory secondary analysis of ENCHANTED2/MT, randomized BP management strategy and early post-thrombectomy BP dynamics showed sex-stratified associations with outcomes. These associations may reflect biological sex and sex-related differences in baseline clinical and vascular characteristics. These findings are hypothesis generating and should be confirmed in prospectively designed studies before informing sex-specific BP management after EVT. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov number, NCT04140110; the Registration Date, October 22, 2019.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Gu R, Zhu X, Wang Z, et al. Sex Differences in Blood Pressure Dynamics and Outcomes After Endovascular Thrombectomy. Neurology. 2026. PMID: 43002720. doi:10.1212/WNL.0000000000218703

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。